Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma

NCT03535350 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Ibrutinib
RADIATION: Radiation
DRUG: Temozolomide (TMZ)

Sponsor

Case Comprehensive Cancer Center